Roberto Mina

3.4k citations
102 papers · 2.3k · 3 hit papers · h-index 22

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
  • Oncology top 10%
    • CAR-T cell therapy research
    • COVID-19 and healthcare impacts
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Multiple Myeloma Research and Treatments 93
    • Acute Myeloid Leukemia Research 1
    • CAR-T cell therapy research 6
    • COVID-19 and healthcare impacts 2

Roberto Mina

94 papers receiving 2.2k citations

Roberto Mina's Hit Papers

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma 2025 · 26 citations
260+1+2Years since publication100200300

Peers

Roberto Mina
Comparison fields: 5 of 51
  • Hematology 1.9k
  • Oncology 199
  • Infectious Diseases 82
  • Genetics 30
  • Geriatrics and Gerontology 11
Replace Angelo Belotti with:
Angelo Belotti Italy
Ivetta Danylesko Israel
Nisha S. Joseph United States
John R Jones United Kingdom
Susana Vives Spain
G. Alimena Italy
Benjamin Kent Tomlinson United States
Karamjeet Sandhu United States
Mahasweta Gooptu United States
Mercedes Gironella Spain
Roberto Mina relative to Angelo Belotti Italy Angelo Belotti's profile →
Citations per field
00.5×2×4×6.1×
Angelo Belotti · 1×
Citations per year

Countries citing papers authored by Roberto Mina

Since Specialization
Citations

This map shows the geographic impact of Roberto Mina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Mina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Mina more than expected).

Fields of papers citing papers by Roberto Mina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Mina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Mina. The network helps show where Roberto Mina may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Mina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Mina Line = papers co-authored together Roberto Mina links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Hit paper breakdown →
2023358
2 2014185
3 2013184
4
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Hit paper breakdown →
2023143
5 201685
6 201381
7 201380
8 201366
9 202261
10 202154
11 201949
12 201446
13 201846
14 201942
15 201741
16 201941
17 201840
18 202140
19 201634
20 201229

About Roberto Mina

Roberto Mina is a scholar working on Hematology, Oncology, Infectious Diseases, Transplantation and Genetics, having authored 102 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (93 papers), CAR-T cell therapy research (6 papers), COVID-19 Clinical Research Studies (3 papers), COVID-19 and healthcare impacts (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (1.9k citations), Oncology (199 citations), Infectious Diseases (82 citations), Genetics (30 citations) and Geriatrics and Gerontology (11 citations). Roberto Mina has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Antonio Pierangelo Palumbo, Francesca Gay, Mario Boccadoro, Sara Bringhen, Sagar Lonial, Alessandra Larocca, Francesca Bonello, Chiara Cerrato, Mattia D’Agostino and Stefania Oliva. Their work appears in journals such as Blood, Haematologica, The Lancet Haematology, New England Journal of Medicine and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact